Doximity (DOCS) Insider Files Form 144 for 20,000-Share Sale

Rhea-AI Filing Summary

Form 144 filing for Doximity, Inc. (DOCS) shows a proposed sale of 20,000 common shares through Morgan Stanley Smith Barney on 09/24/2025 with an aggregate market value of $1,500,000. The shares were acquired via a stock option exercise on 09/24/2025 and paid for in cash. The filing lists 187,299,459 shares outstanding for the class. The notice also discloses prior sales by the same person, Timothy Cabral: 6,360 shares on 09/02/2025 for $421,655.28, 20,000 shares on 08/15/2025 for $1,275,566.00, and 10,000 shares on 06/25/2025 for $600,000. The filer certifies they are not aware of any undisclosed material adverse information.

Positive

• Transparent disclosure of proposed sale and recent insider transactions under Rule 144
• Sale tied to option exercise with cash payment, indicating standard compensation realization rather than debt-for-equity or non-cash consideration

Negative

• Multiple insider sales totaling 36,360 shares in the past three months, which may concern some investors about insider liquidity
• Filer did not provide relationship to issuer or plan adoption date in the notice, limiting context on trading plan or Rule 10b5-1 coverage

Insights

Securities Analyst

TL;DR Insider exercising options and selling shares disclosed; amounts are notable but represent a small fraction of outstanding stock.

The filing documents a routine Rule 144 notice: a 20,000-share sale arising from a same-day stock option exercise with cash payment. Recent aggregated sales by the same individual total 36,360 shares over the last three months. Relative to the stated 187.3 million shares outstanding, these transactions are immaterial to capital structure yet they increase free float. For investors, this is a transparency event rather than evidence of company-level deterioration because no confidential adverse information is claimed.

Corporate Governance Expert

TL;DR Multiple recent insider sales merit attention for governance context but lack additional corporate disclosures.

The notice ties the sale to option exercise and lists sequential dispositions across June–September 2025 by the same individual. While exercising and selling shares can be standard compensation monetization, repeated insider sales over a short period can raise governance questions about insider liquidity and incentive alignment. The filing, however, contains no allegation of undisclosed material information and provides no plan-adoption date or additional commentary, limiting assessment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	1500000.00	187299459	09/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/24/2025	Stock Option Exercise	ISSUER			20000	09/24/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	09/02/2025	6360	421655.28
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	08/15/2025	20000	1275566.00
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	06/25/2025	10000	600000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DOCS Form 144 filing disclose?

The filing discloses a proposed sale of 20,000 common shares on 09/24/2025 through Morgan Stanley with an aggregate market value of $1,500,000.

How were the shares acquired according to the DOCS filing?

The 20,000 shares were acquired by stock option exercise on 09/24/2025 and paid for in cash.

Who sold shares in prior transactions disclosed in the filing?

The filing lists TIMOTHY CABRAL as the seller of 6,360 shares on 09/02/2025, 20,000 shares on 08/15/2025, and 10,000 shares on 06/25/2025.

What is the number of shares outstanding reported in the Form 144?

The filing reports 187,299,459 shares outstanding for the class referenced.

Does the filer claim any undisclosed material information in the DOCS Form 144?

By signing the notice, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.